CSPHF (CStone Pharmaceuticals) Interest Expense: $-1.87 Mil (TTM As of Dec. 2025)


CSPHF CStone Pharmaceuticals CSPHF
47 GF Score
Price $0.59
GF Value $0.12
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is CStone Pharmaceuticals Interest Expense?

CStone Pharmaceuticals CSPHF -14.46% 47 Interest Expense is $-1.87 Mil as of Dec. 2025. GuruFocus rates CSPHF with a GF Score™ of 47/100 and a GF Value™ of $0.12 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. CStone Pharmaceuticals's interest expense for the six months ended in Dec. 2025 was $ -0.90 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was $-1.87 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. CStone Pharmaceuticals's Operating Income for the six months ended in Dec. 2025 was $ -21.09 Mil. CStone Pharmaceuticals's Interest Expense for the six months ended in Dec. 2025 was $ -0.90 Mil. CStone Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CStone Pharmaceuticals  (OTCPK:CSPHF) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

CStone Pharmaceuticals's Interest Expense for the six months ended in Dec. 2025 was $-0.90 Mil. Its Operating Income for the six months ended in Dec. 2025 was $-21.09 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2025 was $22.28 Mil.

CStone Pharmaceuticals's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

CStone Pharmaceuticals did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

CStone Pharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for CStone Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CStone Pharmaceuticals Interest Expense Chart

CStone Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.35 -1.22 -1.66 -2.08 -1.88

CStone Pharmaceuticals Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.83 -1.15 -0.94 -0.96 -0.90
CSPHF
47GF Score
CStone Pharmaceuticals CSPHF
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CStone Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-1.87 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-1.87 Mil mean?
CStone Pharmaceuticals (CSPHF) has a Interest Expense of $-1.87 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on CStone Pharmaceuticals and its competitors.
Is CStone Pharmaceuticals' Interest Expense too high?
CStone Pharmaceuticals' current Interest Expense is $-1.87 Mil. Overall, CStone Pharmaceuticals has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CStone Pharmaceuticals' Interest Expense compare to VRTX and REGN?
CStone Pharmaceuticals' Interest Expense of $-1.87 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on CStone Pharmaceuticals and its competitors. CStone Pharmaceuticals's current Interest Expense is $-1.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CStone Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, CStone Pharmaceuticals (CSPHF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.12, compared to a current price of $0.59 — trading 395.4% above its estimated fair value. The current Interest Expense is $-1.87 Mil. CStone Pharmaceuticals' overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For CStone Pharmaceuticals (CSPHF), the current Interest Expense is $-1.87 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CStone Pharmaceuticals (CSPHF) Overvalued in 2026?

Based on GuruFocus' analysis, CStone Pharmaceuticals stock appears to be overvalued. The current stock price of $0.59 is trading 395.4% above its estimated GF Value™ of $0.12. GuruFocus considers CStone Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for CSPHF:

  • Interest Expense: $-1.87 Mil
  • GF Value™: $0.12 vs. price of $0.59 (395.4% above fair value)
  • GF Score™: 47/100 with 7 warning signs

No single metric tells the full story. See the CSPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CStone Pharmaceuticals Business Description

Other Exchanges 02616:Hong KongPH4:Germany
Address 218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Suzhou, CHN, 215123
CStone Pharmaceuticals is engaged in developing and commercializing immuno-oncology and molecularly targeted drugs to address unmet medical needs in cancer treatment. The Group has been operating in one reportable segment, being the research and development of high-complex biopharmaceutical products, the sale of pharmaceutical products, and provide license of its IP or commercialisation licenses to customers.
47GF Score

Get the complete analysis for CSPHF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.59
Price
$0.12
GF Value